Kynamro (mipomersen injection for SC use) Prior Authorization Policy
Customize your policy alerts
Sign up for all venturacountyhealthcareplan policy alerts
Know when venturacountyhealthcareplan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prescription benefit prior authorization for Kynamro, an adjunctive lipid-lowering therapy for adults with homozygous familial hypercholesterolemia (HoFH). Approval applies to patients initiating or continuing therapy and requires specialist prescribing or consultation, defined clinical criteria, and renewal every 12 months.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.